Can the study be signed electronically?

Yes. Under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws, electronic signatures are legally valid for most research agreements. Exceptions include documents specifically excluded by statute or institutional policy; check IRB guidance for consent disclosure requirements.

Do patient consents need extra disclosures?

Yes. Consumer-facing or patient-facing consents often require a disclosure that informs the participant of their right to a paper copy and procedures to withdraw consent; follow 15 U.S.C. §7001(c) and your IRB's consumer disclosure checklist.

What authentication is recommended?

Use institutional SSO or two-factor authentication for approvers and consider email plus SMS or identity proofing for remote participants. Strong authentication reduces risk of misattribution in audits.

How do I correct a signed protocol?

Do not alter a signed version. Submit a formal amendment with tracked changes and collect required approvals; maintain the original signed version alongside the amendment for auditability.

Are notarization or witnesses usually required?

Not generally for research consent; some state or institution-specific filings may require notarization or witnesses. Check state notary rules and the institution’s policies before requesting notarization.

How long must I keep study records?

Retention depends on applicable rules: HIPAA requires 6 years (45 CFR §164.530(j)); financial and tax records often three years (IRC §6501(a)); many institutions require seven years post-study. Follow the longest applicable retention rule.

Electronic Signature
Templates
Miscellaneous
Research Neutron Study

Research Neutron Study

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH NEUTRON STUDY AGREEMENT

This Research Neutron Study Agreement (the Agreement) is made and entered into as of (Effective Date), by and between:

Client Name Client Address Principal Investigator / Research Institution Research Institution Address

WHEREAS

WHEREAS, Client Name: seeks to engage Research Institution to conduct neutron-based experimental or analytical work for scientific, commercial, or technical evaluation purposes; and

WHEREAS, Principal Investigator: has the technical expertise, facilities, and regulatory authority necessary to perform a Research Neutron Study in accordance with the terms set forth herein; and

WHEREAS, the parties desire to set forth the scope, compensation, confidentiality protections, and other terms governing the Study.

SCOPE OF WORK

Research Institution shall perform and deliver to Client the neutron research services described below (the Services). All Services shall be performed in accordance with accepted scientific standards, applicable permits, and regulatory requirements.

Detailed Scope of Work and Deliverables Special Protocols or Safety Requirements

Work will involve regulated hazardous or radioactive materials

PAYMENT TERMS

Client shall pay Research Institution for the Services as follows. All payments are due in U.S. dollars unless otherwise agreed in writing.

Total Agreed Fee Payment Schedule

Late payments shall incur a late fee of % per month (or the maximum permitted by law, if lower), calculated monthly on overdue amounts from the invoice due date until paid.

Invoicing Address for Payments

TERM AND TERMINATION

The term of this Agreement shall commence on the Effective Date and continue until the completion of the Services or until the End Date provided below, unless earlier terminated in accordance with this Section.

Commencement Date:

End Date:

Either party may terminate this Agreement for material breach by the other party if such breach is not cured within days after receipt of written notice. Either party may terminate for convenience upon days' prior written notice to the other party.

Upon termination, Client shall pay Research Institution for all Services performed and documented expenses incurred through the effective date of termination, together with reasonable wind-down costs as documented by Research Institution.

CONFIDENTIALITY

“Confidential Information” means non-public technical, scientific, business, financial or other information disclosed by one party to the other, whether oral, written, or electronic, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure. Confidential Information includes, without limitation, experimental data, protocols, sample identities where applicable, and proprietary analysis methods.

Receiving party shall (i) hold Confidential Information in strict confidence using at least the same degree of care it uses to protect its own confidential information, (ii) not use Confidential Information other than to exercise its rights and perform its obligations under this Agreement, and (iii) not disclose Confidential Information to any third party except to employees, contractors or advisors who have a need to know and are bound by confidentiality obligations at least as protective as those herein.

Confidential Information does not include information that: (a) is or becomes publicly available through no fault of the receiving party; (b) is obtained from a third party without breach of an obligation of confidentiality; or (c) is independently developed by the receiving party without use of or reference to the disclosing party’s Confidential Information. The receiving party may disclose Confidential Information to the extent compelled by law or regulation, provided reasonable prior notice is given to the disclosing party to allow it to seek protective measures.

The obligations of confidentiality shall survive termination or expiration of this Agreement for a period of years, except that trade secrets shall be protected for so long as they qualify as trade secrets under applicable law.

INTELLECTUAL PROPERTY AND DATA

Unless otherwise agreed in writing, Research Institution shall retain ownership of proprietary instrumentation, software and underlying intellectual property created independent of this Agreement. Client shall own the raw data and final reports generated specifically for Client under this Agreement, subject to Research Institution’s confidentiality obligations and a license to Research Institution to use aggregated or de-identified data for internal research and publication consistent with confidentiality protections and any export control or regulatory constraints.

LIMITATION OF LIABILITY

Except for breaches of confidentiality, willful misconduct or gross negligence, and liabilities that cannot be excluded or limited by law, neither party shall be liable for indirect, incidental, special or consequential damages, nor for lost profits. The aggregate liability of each party for claims arising out of or relating to this Agreement shall not exceed the total amount paid by Client to Research Institution under this Agreement in the twelve (12) months preceding the claim.

GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of , without regard to its choice-of-law principles. The parties consent to the exclusive jurisdiction of the state and federal courts located within that State for any disputes arising out of this Agreement.

ENTIRE AGREEMENT; AMENDMENT

This Agreement, including any Schedules or attachments executed by the parties, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings and communications, whether written or oral. Any amendment or modification of this Agreement must be in writing and signed by authorized representatives of both parties.

MISCELLANEOUS

Notices shall be in writing and delivered to the addresses set forth above or to such other address as either party may designate in writing. If any provision of this Agreement is held unenforceable, the remaining provisions shall remain in full force and effect. Neither party may assign this Agreement without the prior written consent of the other, except that Research Institution may assign to a successor entity in connection with a merger or sale of substantially all of its assets.

Additional Terms or Special Conditions

Principal Investigator (Print Name):

By:

Date:

Client Representative (Print Name):

By:

Date:

What the Research Neutron Study Is and what it contains

The Research Neutron Study is a formal protocol package used to document objectives, methodology, participant consent, safety controls, and data collection procedures for experiments involving neutron measurements or exposure. It generally includes the study protocol, informed consent forms, safety and radiation protection plans, investigator contact information, data management plans, and institutional review board (IRB) documentation. Completing the package precisely enables institutional oversight, supports reproducibility, and documents compliance with applicable human-subjects, radiation safety, and institutional policies.

Why a clear Research Neutron Study matters for compliance and reproducibility

A well-prepared Research Neutron Study clarifies risks, documents consent and approvals, and creates an auditable trail for oversight bodies and sponsors, which reduces regulatory friction and supports scientific integrity.

Who typically prepares and signs this study

The Research Neutron Study is prepared and reviewed by a small set of institutional roles responsible for design, safety, and ethics.

Principal investigator and research staff who design and operate neutron measurements and ensure procedural controls.
Radiation safety officers and environmental health and safety personnel who verify monitoring, shielding, and exposure limits.
IRB administrators, legal counsel, and institutional officials who confirm consent language and regulatory compliance.

Responsibilities often overlap; use the fillable fields and signature blocks to record precise role, affiliation, and delegations for audits and sponsor review.

Essential components to include in a professional Research Neutron Study

Include clear protocol sections, consent materials, safety plans, data handling instructions, signatory blocks, and version control metadata to meet institutional and regulatory expectations.

Protocol Summary

A concise aim and methods overview describing objectives, experimental setup, neutron sources, expected exposures, measurement endpoints, and inclusion/exclusion criteria for subjects or samples.

Informed Consent

Consent language that explains procedures, risks (radiation and otherwise), benefits, alternatives, and participant rights; include required IRB disclosures and consent version/date.

Safety Plan

Radiation protection measures, monitoring protocols, emergency procedures, PPE requirements, and roles for radiation safety officer and facility personnel.

Data Management

Data capture methods, de-identification steps, storage location, access controls, retention period, and procedures for data sharing and reproducibility.

Approvals

IRB determination letters, institutional radiation safety approvals, and any federal or sponsor approvals, with versioned dates and approval signatures.

Signatures & Versioning

Signature blocks for investigators, safety officers, and approvers plus version control fields (version number, effective date, and amendment history) for auditability.

Key information fields the study must capture

Study Title: Official protocol name

Principal Investigator: Name and contact

IRB ID: IRB protocol number

Effective Date: MM/DD/YYYY

Radiation Safety Officer: Name and contact

Version: Version number

Step-by-step: completing and executing the Research Neutron Study

Follow these sequential steps to prepare, approve, and execute the study while preserving an auditable record for compliance and reporting.

01

Draft Protocol: Prepare the protocol text and safety attachments.
02

Internal Review: Obtain radiation safety and departmental approvals.
03

IRB Submission: Submit materials and respond to IRB queries.
04

Signatures: Collect investigator and approver signatures with dates.

How to set up an online workflow for the Research Neutron Study

Configure a digital workflow that routes drafts for departmental review, captures approvals, and locks the final, approved version for distribution and archiving.

Field	Configuration
Review Order	Assign radiation safety, then IRB, then PI
Authentication	Use institutional SSO or two-factor for approvers
Version Lock	Enable final-version locking after signatures
Audit Trail	Capture timestamps, IPs, and action history

Where to send the Research Neutron Study and how it moves through review

Typical routing moves the document from investigator drafting through safety review, IRB review, and final institutional sign-off before research begins.

Drafting: Investigator prepares and attaches safety exhibits.
Safety Review: Radiation safety officer reviews and approves.
IRB Review: IRB assesses consent, risks, and protections.
Final Sign-off: Institutional official records approval and effective date.

Digital delivery and storage considerations

Use a platform that supports secure storage, detailed audit trails, and authenticated signing to preserve the study record.

File Formats: PDF/A and DOCX supported
Integrations: Connect to institutional drives and LMS
Access Controls: Role-based permissions

Timelines you should track for approvals and reporting

Track submission, approval, annual review, and amendment deadlines to avoid lapses in approval that can halt research or invalidate data collection.

Initial IRB Submission:

Submit before planned enrollment or data collection start

IRB Continuing Review:

Annual review or as required by IRB determination

Amendments:

Submit before implementing protocol changes

Adverse Event Reporting:

Report per IRB and sponsor timeframes

Final Report:

Submit within sponsor or funding agency deadlines

Key milestones from protocol draft to archived record

The following milestones show a typical sequential lifecycle; document each stage with timestamps to support audits and reporting.

01

Protocol Drafted

Investigator completes initial protocol draft and attachments.

02

Safety Approval

Radiation safety sign-off recorded with conditions if any.

03

IRB Approval

IRB issues approval letter and effective date.

04

Final Archival

Approved version stored with signatures and audit trail.

Common mistakes to avoid when preparing the study

Submitting inconsistent participant identifiers or consent versions that differ from the IRB-approved text, which can lead to noncompliance findings and require corrective action.
Failing to document radiation monitoring methods or dose estimates clearly, causing safety reviewers to request revisions or impose additional controls before approval.
Omitting required signatures or using initials where full signatory blocks are required, which can delay approval and invalidate participant enrollment.
Not maintaining version control or audit logs for protocol amendments, making it difficult to demonstrate which procedures were in effect for specific data sets.

Penalties and risks of incomplete or incorrect study documentation

IRB Noncompliance: Institutional sanctions possible

Data Inadmissible: Regulatory or sponsor rejection

Patient Harm: Safety incidents and liability

Funding Risk: Sponsor withholding payments

Legal Exposure: Civil claims or enforcement

Reporting Violations: Adverse event reporting fines

eSignature vendor pricing and compliance snapshot for study documentation

Compare starting prices and key compliance features to choose a platform that supports audit trails, HIPAA needs, and your expected envelope volume.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	Yes
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Frequently asked questions about completing and submitting the Research Neutron Study

Answers to common questions about signatures, consent versions, IRB linkage, and electronic submission. If an issue persists consult institutional offices listed in the form.

Need help? Contact support

Can the study be signed electronically?
Yes. Under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws, electronic signatures are legally valid for most research agreements. Exceptions include documents specifically excluded by statute or institutional policy; check IRB guidance for consent disclosure requirements.
Do patient consents need extra disclosures?
Yes. Consumer-facing or patient-facing consents often require a disclosure that informs the participant of their right to a paper copy and procedures to withdraw consent; follow 15 U.S.C. §7001(c) and your IRB's consumer disclosure checklist.
What authentication is recommended?
Use institutional SSO or two-factor authentication for approvers and consider email plus SMS or identity proofing for remote participants. Strong authentication reduces risk of misattribution in audits.
How do I correct a signed protocol?
Do not alter a signed version. Submit a formal amendment with tracked changes and collect required approvals; maintain the original signed version alongside the amendment for auditability.
Are notarization or witnesses usually required?
Not generally for research consent; some state or institution-specific filings may require notarization or witnesses. Check state notary rules and the institution’s policies before requesting notarization.
How long must I keep study records?
Retention depends on applicable rules: HIPAA requires 6 years (45 CFR §164.530(j)); financial and tax records often three years (IRC §6501(a)); many institutions require seven years post-study. Follow the longest applicable retention rule.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now